STELID II/STELIX/STELIX II ENDOCARDIAL PACING LEAD

Drug Eluting Permanent Right Ventricular (rv) Or Right Atrial (ra) Pacemaker Electrodes

FDA Premarket Approval P020030

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the stelid ii, stelix, and stelix ii endocardial pacing leads. The stelid ii, stelix, and stelix ii endocardial steroid eluting pacing leads are designed to be used with an implantable pacemaker for pacing and sensing of the heart. The stelid ii models btf25d/26d and utf25d/26d are intended for permanent pacing and sensing of the ventricle. The stelid ii models bjf24d/25d, stelix models br45d/46d, and stelix ii models brf25d/26d are intended for permanent pacing and sensing of the atrium.

DeviceSTELID II/STELIX/STELIX II ENDOCARDIAL PACING LEAD
Classification NameDrug Eluting Permanent Right Ventricular (rv) Or Right Atrial (ra) Pacemaker Electrodes
Generic NameDrug Eluting Permanent Right Ventricular (rv) Or Right Atrial (ra) Pacemaker Electrodes
ApplicantMicroPort CRM USA Inc.
Date Received2002-07-19
Decision Date2004-06-17
Notice Date2004-07-16
PMAP020030
SupplementS
Product CodeNVN
Docket Number04M-0310
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product Yes
Applicant Address MicroPort CRM USA Inc. 5640 Airline Road arlington, TN 38002
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P020030Original Filing
S010 2013-09-11 30-day Notice
S009 2012-01-27 30-day Notice
S008 2011-02-28 30-day Notice
S007 2010-08-23 135 Review Track For 30-day Notice
S006 2010-03-30 30-day Notice
S005
S004 2007-10-11 135 Review Track For 30-day Notice
S003 2006-05-25 Real-time Process
S002 2005-07-21 135 Review Track For 30-day Notice
S001 2004-07-16 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.